Replies to post #1721 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA’s General Counsel exercised and held $150K of stock today—the second such insider transaction recently:

https://www.sec.gov/Archives/edgar/data/1177648/000117764818000053/xslF345X03/edgar.xml

The exercised options did not expire until 2024.